Cargando…
Doxazosin for the treatment of nightmare disorder: A diary-based case study
The α(1)-adrenergic antagonist prazosin has showed good effect against posttraumatic stress disorder–related nightmares in several randomized controlled trials. The α(1)-adrenergic antagonist doxazosin, which has a longer half-live than prazosin, has received far less attention in the treatment of s...
Autores principales: | Pallesen, Ståle, Hamre, Hilde Sofie, Lang, Nina, Bjorvatn, Bjørn |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7325538/ https://www.ncbi.nlm.nih.gov/pubmed/32647580 http://dx.doi.org/10.1177/2050313X20936079 |
Ejemplares similares
-
Treating nightmares in PTSD with doxazosin: a report of three cases
por: Calegaro, Vitor Crestani, et al.
Publicado: (2019) -
The Effects of Pharmacological Treatment of Nightmares: A Systematic Literature Review and Meta-Analysis of Placebo-Controlled, Randomized Clinical Trials
por: Skeie-Larsen, Mathilda, et al.
Publicado: (2022) -
Insomnia – A Heterogenic Disorder Often Comorbid With Psychological and Somatic Disorders and Diseases: A Narrative Review With Focus on Diagnostic and Treatment Challenges
por: Bjorvatn, Bjørn, et al.
Publicado: (2021) -
Editorial: Insomnia: A Heterogenic Disorder Often Comorbid With Other Disorders and Diseases
por: Jernelöv, Susanna, et al.
Publicado: (2021) -
Sleep and Sleepiness Measured by Diaries and Actigraphy among Norwegian and Austrian Helicopter Emergency Medical Service (HEMS) Pilots
por: Flaa, Tine Almenning, et al.
Publicado: (2022)